Correlation Between Achilles Therapeutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Larimar Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Larimar Therapeutics.
Diversification Opportunities for Achilles Therapeutics and Larimar Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Achilles and Larimar is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Larimar Therapeutics
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.25 times more return on investment than Larimar Therapeutics. However, Achilles Therapeutics PLC is 4.02 times less risky than Larimar Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 100.00 in Achilles Therapeutics PLC on September 1, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. Larimar Therapeutics
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| Larimar Therapeutics |
Achilles Therapeutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and Larimar Therapeutics
The main advantage of trading using opposite Achilles Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |